person

Ole Morten R.

Country
Norway
Department
Nevrologisk avdeling

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 264 partner sites.

Specializations

Stroke Prevention

The investigator specializes in the prevention of ischemic stroke, with particular focus on treatment strategies following acute events. Their research interests encompass therapeutic approaches for patients who have experienced non-cardioembolic ischemic strokes or high-risk transient ischemic attacks (TIA).

  • Post-stroke Prevention
  • TIA Management
  • Antithrombotic Therapy

Their work explores innovative therapeutic strategies involving oral FXIa inhibition combined with antiplatelet therapy for stroke prevention.

Cerebrovascular Medicine

The investigator focuses on advancing treatments in cerebrovascular medicine, particularly examining novel approaches to prevent recurrent strokes. Their expertise extends to evaluating bleeding risk management in stroke patients receiving preventive treatments.

  • Stroke Risk Assessment
  • Secondary Prevention
  • Bleeding Risk Management

Their research includes evaluation of hemorrhagic complications according to International Society on Thrombosis and Hemostasis criteria.

Therapeutic Innovation

The investigator's work centers on developing enhanced therapeutic strategies for stroke prevention. Their research explores the combination of novel pharmaceutical agents with established antiplatelet therapy regimens.

  • Novel Therapeutic Agents
  • Combination Therapy
  • Clinical Efficacy Assessment

Their investigations focus on optimizing treatment outcomes in patients with acute cerebrovascular events.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.